Opus Genetics, Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $0 | $0 | $0 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $13.1M | $10.7M | $10.1M | $12.1M | $7.0M | $3.3M | $3.4M | $12.0M |
| SG&A Expense | $7.4M | $6.6M | $6.3M | $6.1M | $6.3M | $4.7M | $2.7M | $3.5M |
| Operating Income | $-20.5M | $-17.4M | $-16.4M | $-18.3M | $-13.3M | $-8.0M | $-6.6M | $-16.1M |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | $0 | $0 | $0 |
| Net Income | $-14.4M | $-25.3M | $-9.3M | $-14.4M | $-18.5M | $-9.5M | $-6.2M | $-11.3M |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | $-0.88 | $-0.15 | $-0.07 | $-0.13 | $-0.02 | $-0.01 | $-0.01 | $-0.02 |
| EPS (Diluted) | $-0.88 | $-0.15 | $-0.07 | $-0.13 | $-0.02 | $-0.01 | $-0.01 | $-0.02 |
| Shares Outstanding (Basic) | 18.7M | 190.4M | 142.4M | 1.18B | 1.07B | 880.3M | 716.6M | 572.1M |
| Shares Outstanding (Diluted) | 18.7M | 190.4M | 142.4M | 1.18B | 1.07B | 880.3M | 716.6M | 572.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |